US FDA approves Mirum Pharma's genetic disorder drug

(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved Mirum Pharmaceuticals' drug to treat a type of rare disorder, which affects the body's ability to metabolize fats known as cholesterol. Patients with the disorder known as cerebrotendinous xanthomatosis are unable to break down cholesterol properly, causing toxins to build up throughout the body over time. The drug